SCHEMBL5041809

SCHEMBL5041809

COc1ccc(C(OC)C(=O)O)cc1OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 2/20 0.56
HDAC1 Q13547 1/20 0.56
HDAC8 Q9BY41 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
F2 P00734 3/20 0.53
F10 P00742 3/20 0.53
PRSS1 P07477 3/20 0.53
F7 P08709 3/20 0.53
PRSS2 P07478 2/20 0.53
F3 P13726 2/20 0.53
PRSS3 P35030 2/20 0.53
NPC1 O15118 1/20 0.51
HPGD P15428 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
MRGPRX4 Q96LA9 2/20 0.50
RXRA P19793 1/20 0.50
POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5047655 0.89 SMPD1 (0.53) SMPD1HDAC1HDAC8HDAC6F2
SCHEMBL7823960 0.85 SMPD1 (0.57) SMPD1HDAC1HDAC8HDAC6F2
SCHEMBL5319215 0.83 ACHE (0.59) HPGDSMN1; SMN2KMT2ACA1CA2
SCHEMBL8843624 0.82 SMPD1 (0.53) SMPD1HDAC1HDAC8HDAC6F2
SCHEMBL2060104 0.82 SMPD1 (0.56) SMPD1HDAC1HDAC8HDAC6F2
SCHEMBL9586284 0.82 SMPD1 (0.56) SMPD1HDAC1HDAC8HDAC6F2
SCHEMBL9416618 0.81 MMP1 (0.55) SMPD1HDAC1HDAC8HDAC6F2
SCHEMBL3565827 0.81 SMPD1 (0.54) SMPD1HDAC1HDAC8HDAC6F2
SCHEMBL17833745 0.80 SMPD1 (0.53) SMPD1HDAC1HDAC8HDAC6F2
SCHEMBL7916416 0.80 NFKB1 (0.57) SMPD1HDAC1HDAC8HDAC6F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 SMPD1 369/4885HDAC1 3142/4885HDAC8 2454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.